Gene: ZKSCAN2
Official Full Name: zinc finger with KRAB and SCAN domains 2provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12365 | ZKSCAN2 Knockout cell line (HeLa) | Human | ZKSCAN2 | 1:3~1:6 | Negative | Online Inquiry |
KO12366 | ZKSCAN2 Knockout cell line (HCT 116) | Human | ZKSCAN2 | 1:2~1:4 | Negative | Online Inquiry |
KO12367 | ZKSCAN2 Knockout cell line (HEK293) | Human | ZKSCAN2 | 1:3~1:6 | Negative | Online Inquiry |
KO12368 | ZKSCAN2 Knockout cell line (A549) | Human | ZKSCAN2 | 1:3~1:4 | Negative | Online Inquiry |
ZKSCAN2 Gene Knockout Cell Lines are specialized cellular models in which the ZKSCAN2 gene, a critical regulator of cellular processes, has been systematically disrupted or "knocked out." This innovative biological product enables researchers to study the specific functions of the ZKSCAN2 gene in various biological pathways, contributing valuable insights into gene regulation, cellular differentiation, and disease mechanisms. The knockout mechanism is achieved through advanced gene-editing technologies, such as CRISPR-Cas9, allowing for precise genomic alterations and the generation of a robust experimental system.
The primary function of ZKSCAN2 Gene Knockout Cell Lines lies in their ability to elucidate the role of ZKSCAN2 in biological processes, such as cell proliferation, apoptosis, and response to stressors. By using these cell lines, researchers can investigate the gene's involvement in pathological conditions including cancer and autoimmune diseases, thus unveiling potential therapeutic targets and biomarkers. The biological relevance of this product is evident in both academic research and clinical applications, as it supports studies aimed at understanding complex diseases at the molecular level.
When compared to alternatives, such as traditional knockdown methods or less defined cellular models, the ZKSCAN2 Gene Knockout Cell Lines offer several advantages: they provide a complete loss-of-function model, eliminate off-target effects commonly associated with RNA interference, and create a stable platform for long-term studies. This specificity enhances experimental reproducibility and reliability.
For researchers and clinicians exploring the intricate workings of gene functions and seeking to advance their understanding of disease biology, the ZKSCAN2 Gene Knockout Cell Lines serve as an indispensable tool. These cell lines significantly enhance the capability to model human diseases, facilitating the discovery of novel therapeutic strategies and contributing to personalized medicine approaches.
Our company takes pride in its expertise in cutting-edge genetic technologies and commitment to providing high-quality biological products that empower scientific research across various disciplines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.